Skip to main content
Premium Trial:

Request an Annual Quote

NIH Proposes Best Practices for Licensing Government-Funded Genomic Inventions

NEW YORK, Dec. 13 (GenomeWeb News) - The National Institutes of Health proposed best practices for licensing government-funded genomic inventions, and is waiting to receive comments from the intramural technology transfer community and funding recipients.

 

The best practices, announced last month, would apply to all genomic inventions, including cDNAs, ESTs, haplotypes, antisense molecules, siRNAs, genes and their products, as well as methods and instruments for genome sequencing, quantification of nucleic acids, detection of SNPs, and genetic modifications.

 

The proposal states that patents for genomic inventions "must balance the rewards of broad intellectual property protection afforded to founders of enabling genomic inventions with the benefits of fostering opportunities for those striving to improve upon those innovations."

 

Therefore, researchers should only seek to patent their inventions "when it is clear that private sector investment will be necessary to develop and make the invention widely available."

 

Since the commercial potential of inventions is often not clear initially, researchers may want to patent them first and decide later whether to license them exclusively or non-exclusively. "Whenever possible, non-exclusive licensing should be pursued as a best practice," the recommendations say.

 

Where exclusive licensing is necessary, it should be "appropriately tailored to ensure expeditions development of as many aspects of the technology as possible," and licsenses should include definite milestones and benchmarks and be "limited to be commensurate with the abilities and commitment of licensees to bring the technology to market expeditiously."

 

The comment period ends Jan. 18, 2005. For the full text of the proposed best practices, click here.

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.